Assuming a high placental inositol level assessed at delivery is reflective of the systemic inositol levels present antenatally, this did not necessarily avert the occurrence of maternal hyperglycaemia in our cohort as would be expected from inositol promotion of insulin sensitivity in maternal tissues [15]. This evidence concerns the gene INS and Hyperglycemia.